BCL11A rs4671393: What Your Genotype Means
The rs4671393 variant is a common genetic change located within the BCL11A gene. It is widely studied for its association with fetal hemoglobin (HbF) levels and its potential to influence the clinical severity of conditions like sickle cell disease.
What each genotype means
Baseline fetal hemoglobin association
This genotype is associated with lower levels of fetal hemoglobin compared to the G allele. In individuals with sickle cell disease, this variant is one of several genetic factors that may influence clinical severity by modulating fetal hemoglobin expression. This association is based on statistical population studies and does not predict individual health outcomes.
This is the less common genotype in many global populations, as the G allele is the major allele at this position.
Intermediate fetal hemoglobin association
This genotype represents a heterozygous state associated with intermediate levels of fetal hemoglobin. Research indicates that the G allele at this position is linked to higher fetal hemoglobin levels, which can act as a modifier of clinical severity in sickle cell disease. Please discuss any concerns regarding your health or clinical management with your physician.
This genotype is commonly observed across diverse ancestral groups.
Elevated fetal hemoglobin association
This genotype is associated with higher levels of fetal hemoglobin, which is a known factor that can help mitigate the severity of sickle cell disease. While this genetic marker is statistically linked to these levels, it is only one of many factors influencing hemoglobin regulation. This information is for educational purposes and should not be used for medical diagnosis.
This is the most common genotype, carried by the majority of individuals in most studied populations.
Understanding the rs4671393 Variant
The rs4671393 variant is a single-nucleotide polymorphism (SNP) located within the BCL11A gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is found in non-coding regions of the gene, which are areas that do not provide instructions for making proteins directly but instead act as regulatory switches. Research indicates that this variant sits within an erythroid enhancer, a specialized DNA sequence that helps control how genes are expressed in red blood cell precursors. By influencing these regulatory elements, the variant can modulate the activity of the BCL11A gene, which in turn affects the production of different types of hemoglobin in the body.
The Role of the BCL11A Gene
The BCL11A gene provides instructions for creating a protein that acts as a transcriptional repressor. Its primary function in the context of blood development is to silence the production of fetal hemoglobin (HbF) as a person transitions from infancy to adulthood. Fetal hemoglobin is the primary type of oxygen-carrying protein in a developing fetus, but it is typically replaced by adult hemoglobin shortly after birth. When BCL11A is active, it effectively turns off the genes responsible for HbF. Because HbF can compensate for the defective hemoglobin found in sickle cell disease and beta-thalassemia, the regulation of this gene is a major focus of hematological research. Variations that reduce BCL11A activity can lead to higher levels of persistent fetal hemoglobin.
Research and Clinical Associations
Scientific studies have consistently identified rs4671393 as a quantitative trait locus for fetal hemoglobin levels. In patients with sickle cell disease, higher levels of HbF are associated with a milder clinical phenotype, as the fetal hemoglobin helps prevent the red blood cells from sickling. Consequently, researchers have investigated whether the variant alleles at rs4671393 contribute to this protective effect. While the evidence strongly links this variant to HbF levels, it is important to note that the clinical impact is complex and influenced by many other genetic and environmental factors. The evidence for its role in modifying disease severity is considered significant but should be viewed as part of a broader genetic landscape rather than a sole determinant of health outcomes.
Population Frequency and Interpretation
The rs4671393 variant is considered common across many global populations. Because it is a common variant, most individuals will carry at least one copy of the minor or major allele. Its frequency does not imply that it is a disease-causing mutation in the traditional sense, but rather a natural variation that contributes to the diversity of human physiological traits. When interpreting information about this SNP, it is essential to understand that genetic associations are statistical in nature. They describe trends observed in large groups of people rather than predicting the health of a specific individual. This information is intended for educational purposes and should not be used to make medical decisions or to assess personal risk without the guidance of a qualified healthcare professional.
What You Can Do With This Information
Understanding your genetic profile regarding rs4671393 can be an interesting way to learn about the biological mechanisms that regulate hemoglobin. However, it is crucial to recognize the limitations of this data. This variant is not a diagnostic tool, and it cannot predict the specific severity of any blood disorder. If you or a family member are living with a condition like sickle cell disease or thalassemia, the most important steps involve working closely with a hematologist or a genetic counselor. They can provide context based on your full clinical history, family background, and other relevant diagnostic tests. Never change or stop any prescribed medication based on genetic information without first consulting your clinician or pharmacist, as they are the only ones who can safely manage your treatment plan.
How common is this variant?
The rs4671393 variant is a common polymorphism found across diverse ancestral populations, with varying frequencies of the C and T alleles.
Frequently asked questions
Is rs4671393 a cause of sickle cell disease?
No, rs4671393 is not a cause of sickle cell disease. It is a common genetic variant that may influence the severity of the condition by affecting fetal hemoglobin levels, but it does not cause the disease itself.
Can I use this SNP to predict my health?
No, this SNP cannot be used to predict your health. Genetic associations are statistical observations across populations and do not provide a diagnosis or a definitive health forecast for an individual.
What does it mean if I have the T/T genotype?
The T/T genotype is associated with higher levels of fetal hemoglobin in some studies. However, this is a complex trait influenced by many other genes and environmental factors, so it does not guarantee a specific health outcome.
Should I talk to my doctor about this variant?
If you have concerns about your health or a family history of blood disorders, it is always appropriate to discuss them with your doctor. They can help you understand the relevance of any genetic information in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4671393?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BCL11A
This polymorphism influences fetal hemoglobin expression and is linked to the clinical course of sickle cell disease.
A variant in the BCL11A gene that modulates fetal hemoglobin levels and impacts the severity of sickle cell anaemia complications.